Inventor · disambiguated record
Bradley R. Pearse
Also filed as: PEARSE BRADLEY · PEARSE BRADLEY R
7 granted patents·14 pending applications·23 citations·filing 2015–2024
80Inventor score
Files withMAGENTA THERAPEUTICS INC11BIOGEN MA INC5CRISPR THERAPEUTICS AG2VOR BIOPHARMA INC2BIOVERATIV THERAPEUTICS INC1
Top patents by PatentIndex Score
21 records- 0192US10899843B2Compositions and methods for the depletion of CD117+ cellsMAGENTA THERAPEUTICS INC·Filed 2018·Granted Jan 26, 2021·8 cites·38 claims
- 0291US10882915B2Compositions and methods for the depletion of CD117+ cellsMAGENTA THERAPEUTICS INC·Filed 2018·Granted Jan 5, 2021·9 cites·27 claims
- 0389US11572411B2Anti-CD117 antibodies and conjugatesMAGENTA THERAPEUTICS INC·Filed 2020·Granted Feb 7, 2023·2 cites·14 claims
- 0484US11958908B2Compositions and methods for the depletion of CD117+ cellsCRISPR THERAPEUTICS AG·Filed 2020·Granted Apr 16, 2024·1 cites·26 claims
- 0581US10875924B2Anti-GPIIB/IIIA antibodies and uses thereofBIOGEN MA INC·Filed 2015·Granted Dec 29, 2020·3 cites·16 claims
- 0678US2024360238A1Compositions and methods for the depletion of cd117+ cellsCRISPR THERAPEUTICS AG·Filed 2024·Application pending·0 cites
- 0776US12209135B2Anti-CD45 antibodies and conjugates thereofVOR BIOPHARMA INC·Filed 2024·Granted Jan 28, 2025·0 cites·22 claims
- 0867US2022089745A1ANTI-GLYCOPROTEIN IIb/IIIa ANTIBODIESBIOGEN MA INC·Filed 2021·Application pending·0 cites
- 0966US2024075157A1Fc silenced antibody drug conjugates (adcs) and uses thereofMAGENTA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1064US2020354459A1ANTI-GLYCOPROTEIN IIb/IIIa ANTIBODIESBIOGEN MA INC·Filed 2019·Application pending·0 cites
- 1157US2021246212A1Anti-gpiib/iiia antibodies and uses thereofBIOGEN MA INC·Filed 2020·Application pending·0 cites
- 1256US2022177578A1Anti-cd117 antibodies and uses thereofMAGENTA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1356US2022177575A1Anti-cd117 antibodies and uses thereofMAGENTA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1456US2022175946A1Conditioning methods for gene therapyMAGENTA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1554US2020376135A1Fc silenced antibody drug conjugates (adcs) and uses thereofMAGENTA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1654US2023183344A1T-cell bispecific binding proteinsMAGENTA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1753US12291576B2Anti-CD45 antibodies and conjugates thereofVOR BIOPHARMA INC·Filed 2021·Granted May 6, 2025·0 cites·26 claims
- 1852US2017342152A1ANTI-GLYCOPROTEIN IIb/IIIa ANTIBODIESBIOGEN MA INC·Filed 2015·Application pending·0 cites
- 1951US2022175951A1Anti-CD45 Antibody Drug Conjugates and Uses ThereofMAGENTA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2046US2020255523A1Fc silenced antibody drug conjugates (adcs) and uses thereofMAGENTA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2140US2023192896A1Bispecific antibodies binding to coagulation factor ix and coagulation factor xBIOVERATIV THERAPEUTICS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bradley R. Pearse files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →